more

Thermo Fisher Scientific (TMO)

(Real Time Quote from BATS)

$607.26 USD

-11.20 (-1.81%)

Updated Sep 12, 2024 12:20 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank	Definition	Annualized Return
1	Strong Buy	23.68%
2	Buy	17.55%
3	Hold	9.21%
4	Sell	4.93%
5	Strong Sell	2.36%
S&P	500	10.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5 3

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score	A
Growth Score	A
Momentum Score	A
VGM Score	A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value D Growth B Momentum C VGM

Industry Rank:

Top 29% (72 out of 250)

Industry: Medical - Instruments

View All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Medical Products Stock Feb 6 Earnings Roster: BDX, CAH & More

by Zacks Equity Research Published on February 05,2020

Despite the ongoing US-China trade war, increased focus on innovation is likely to have driven performance of medical products players' quarterly performance.

Thermo Fisher (TMO) Q4 Earnings Top, Organic Growth Solid

by Zacks Equity Research Published on January 30,2020

We are upbeat that two of Thermo Fisher's (TMO) four business segments deliver strong year-over-year revenue growth in Q4.

Thermo Fisher Scientific (TMO) Q4 Earnings and Revenues Surpass Estimates

by Zacks Equity Research Published on January 30,2020

Thermo Fisher (TMO) delivered earnings and revenue surprises of 0.28% and 0.67%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?

TMONegative Net Change

Why Thermo Fisher Scientific (TMO) Might Surprise This Earnings Season

by Zacks Equity Research Published on January 29,2020

Thermo Fisher Scientific (TMO) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

TMONegative Net Change

Medical Products' Jan 30 Earnings Roster: TMO, EW & More

by Zacks Equity Research Published on January 29,2020

Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have contributed to the performance of the players in the medical products space this earnings season.

What's in Store for Thermo Fisher (TMO) in Q4 Earnings?

by Zacks Equity Research Published on January 27,2020

Strength in segments is expected to get reflected in Thermo Fisher's (TMO) fourth-quarter and 2019 top-line numbers.

medical

Thermo Fisher Scientific (TMO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

by Zacks Equity Research Published on January 23,2020

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

TMONegative Net Change

Thermo Fisher Hits New 52-Week High: What's Driving the Stock?

by Zacks Equity Research Published on January 13,2020

Thermo Fisher (TMO) is optimistic about maintaining its growth momentum on several recent developments.

medical

Why Thermo Fisher (TMO) is Poised to Beat Earnings Estimates Again

by Zacks Equity Research Published on January 09,2020

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

TMONegative Net Change

Is Thermo Fisher Scientific (TMO) Outperforming Other Medical Stocks This Year?

by Zacks Equity Research Published on January 08,2020

Is (TMO) Outperforming Other Medical Stocks This Year?

TMONegative Net Change

Thermo Fisher Rides on New Product Suite, Currency Woes Stay

by Zacks Equity Research Published on January 02,2020

Thermo Fisher Scientific (TMO) recently unveils a product suite comprising the TSQ Altis, Quantis MD mass spectrometers and Vanquish MD HPLC.

medical

Here's Why You Should Retain Pacific Biosciences Stock Now

by Zacks Equity Research Published on December 30,2019

Pacific Biosciences (PACB) continues to gain from innovative product portfolio and Sequel system. However, stiff competition remains a woe.

medical

Here's Why You Should Hold on to Thermo Fisher Stock for Now

by Zacks Equity Research Published on December 27,2019

Investors continue to be optimistic about Thermo Fisher (TMO) on its stellar segmental performance.

medical

The Zacks Analyst Blog Highlights: QUALCOMM, NVIDIA, Charter, Microsoft and Thermo Fisher Scientific

by Zacks Equity Research Published on December 17,2019

The Zacks Analyst Blog Highlights: QUALCOMM, NVIDIA, Charter, Microsoft and Thermo Fisher Scientific

semiconductor

5 Corporate Giants That Popped in 2019 and Have Upside Left

by Nalak Das Published on December 16,2019

A stable U.S. economy, a partial trade deal with China, possible solution of Brexit and easy monetary policy of the Fed are likely to sustain Wall Street's rally in 2020.